NCT07576595 · Louisiana State University Health Sciences Center in New Orleans
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
What this study is about
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
View original scientific description
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
Interventions
BEHAVIORAL
Smoking cessation multilevel Intervention
The intervention will utilize a multilevel intervention based on the Social Ecological Model's individual, institutional, and community levels.
Primary outcome measures
Stage of Change for Smoking Cessation
Time frame: Baseline, immediately post-intervention, and 6-month follow-up
Stage of change in smoking cessation behavior
7-Day Point Prevalence Abstinence Rate
Time frame: Baseline, immediately post-intervention, and 6-month follow-up
Proportion of participants reporting no smoking in the past 7 days
24-Hour Point Prevalence Abstinence Rate
Time frame: Baseline, immediately post-intervention, and 6-month follow-up
Proportion of participants reporting no smoking in the past 24 hours
Daily Cigarette Consumption
Time frame: Baseline, immediately post-intervention, and 6-month follow-up
Number of cigarettes smoked per day
Nicotine Dependence (Fagerström Test for Nicotine Dependence)
Time frame: Baseline, immediately post-intervention, and 6-month follow-up
Nicotine dependence measured using the Fagerström Test for Nicotine Dependence (FTND), range 0-10, higher scores indicate greater dependence
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- African American
- 20+ pack years of smoking
- eligible for or received LDCT screening
- current smoker
- English speaking
Where
- New Orleans, Louisiana
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced May 11, 2026 · Source of record for eligibility and locations